Articoli con mandati relativi all'accesso pubblico - julien TaiebUlteriori informazioni
Non disponibili pubblicamente: 9
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
M Suker, BR Beumer, E Sadot, L Marthey, JE Faris, EA Mellon, ...
The Lancet Oncology 17 (6), 801-810, 2016
Mandati: US National Institutes of Health
Immunomodulatory activity of VEGF in cancer
A Lapeyre-Prost, M Terme, S Pernot, AL Pointet, T Voron, E Tartour, ...
International review of cell and molecular biology 330, 295-342, 2017
Mandati: Swiss Cancer League
Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm …
S Kim, E François, T André, E Samalin, M Jary, F El Hajbi, N Baba-Hamed, ...
The Lancet Oncology 19 (8), 1094-1106, 2018
Mandati: Swiss Cancer League
Prognostic Value and Relation with Adjuvant Treatment Duration of ctDNA in Stage III Colon Cancer: a Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France …
J Taieb, V Taly, J Henriques, C Bourreau, L Mineur, J Bennouna, ...
Clinical Cancer Research 27 (20), 5638-5646, 2021
Mandati: National Institute of Health and Medical Research, France
Does neoadjuvant FOLFOX chemotherapy improve the prognosis of high‐risk stage II and III colon cancers? Three years' follow‐up results of the PRODIGE 22 phase II randomized …
M Karoui, C Gallois, G Piessen, JL Legoux, E Barbier, C De Chaisemartin, ...
Colorectal Disease 23 (6), 1357-1369, 2021
Mandati: Swiss Cancer League
Prognostic impact of early treatment and oxaliplatin discontinuation in patients with stage III colon cancer: an ACCENT/IDEA pooled analysis of 11 adjuvant trials
C Gallois, Q Shi, JP Meyers, T Iveson, SR Alberts, A De Gramont, ...
Journal of Clinical Oncology 41 (4), 803-815, 2023
Mandati: Cancer Research UK
Immune therapy in colorectal cancer
A Lapeyre-Prost, M Terme, S Pernot, E Marcheteau, AL Pointet, T Voron, ...
Colorectal Cancer 6 (1), 1-10, 2017
Mandati: Swiss Cancer League
Feasibility of 3-dimensional-printed model assisting endoscopic resection of gastrointestinal submucosal tumors
Q Luo, XL Yuan, LS Ye, B Hu
Digestive and Liver Disease 54 (6), 845-848, 2022
Mandati: National Natural Science Foundation of China
Case histories in unresectable liver-dominant metastatic colorectal cancer
RA Sharma, M Peeters, J Taieb
Future Oncology 10 (sup15), 41-47, 2014
Mandati: Cancer Research UK, UK Medical Research Council, National Institute for …
Disponibili pubblicamente: 79
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
E Van Cutsem, A Cervantes, R Adam, A Sobrero, JH Van Krieken, ...
Annals of Oncology 27 (8), 1386-1422, 2016
Mandati: Cancer Research UK, National Institute for Health Research, UK
VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors
T Voron, O Colussi, E Marcheteau, S Pernot, M Nizard, AL Pointet, ...
Journal of Experimental Medicine 212 (2), 139-148, 2015
Mandati: Swiss Cancer League
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
G Argilés, J Tabernero, R Labianca, D Hochhauser, R Salazar, T Iveson, ...
Annals of Oncology 31 (10), 1291-1305, 2020
Mandati: US National Institutes of Health, Fondazione AIRC per la Ricerca sul Cancro
Duration of adjuvant chemotherapy for stage III colon cancer
A Grothey, AF Sobrero, AF Shields, T Yoshino, J Paul, J Taieb, ...
New England Journal of Medicine 378 (13), 1177-1188, 2018
Mandati: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma …
V Vilgrain, H Pereira, E Assenat, B Guiu, AD Ilonca, GP Pageaux, A Sibert, ...
The Lancet Oncology 18 (12), 1624-1636, 2017
Mandati: National Institute of Health and Medical Research, France
A novel dendritic cell subset involved in tumor immunosurveillance
J Taieb, N Chaput, C Ménard, L Apetoh, E Ullrich, M Bonmort, ...
Nature medicine 12 (2), 214-219, 2006
Mandati: German Research Foundation
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE …
HS Wasan, P Gibbs, NK Sharma, J Taieb, V Heinemann, J Ricke, ...
The Lancet Oncology 18 (9), 1159-1171, 2017
Mandati: Cancer Research UK, National Institute for Health Research, UK
Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with …
E Tartour, H Pere, B Maillere, M Terme, N Merillon, J Taieb, F Sandoval, ...
Cancer and Metastasis Reviews 30, 83-95, 2011
Mandati: National Institute of Health and Medical Research, France
Control of the immune response by pro-angiogenic factors
T Voron, E Marcheteau, S Pernot, O Colussi, E Tartour, J Taieb, M Terme
Frontiers in oncology 4, 70, 2014
Mandati: Swiss Cancer League
Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer
J Taieb, K Le Malicot, Q Shi, F Penault-Llorca, O Bouché, J Tabernero, ...
Journal of the National Cancer Institute 109 (5), djw272, 2017
Mandati: US National Institutes of Health
Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised …
CS Fuchs, K Shitara, M Di Bartolomeo, S Lonardi, SE Al-Batran, ...
The Lancet Oncology 20 (3), 420-435, 2019
Mandati: German Research Foundation
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software